Literature DB >> 7476054

Clenbuterol: a substitute for anabolic steroids?

I D Prather1, D E Brown, P North, J R Wilson.   

Abstract

Clenbuterol is a recently popular drug used by athletes in many sports for its purported anabolic effects and reduction of subcutaneous fat. It is a beta-2 (beta 2) agonist prescribed overseas as a bronchodilator, but not approved for use in this country. It is on the banned substance list of the United States Olympic Committee. To avoid any erosion of confidence, physicians caring for athletes need accurate information regarding clenbuterol. Such information is unavailable within the routine medical environs. A review of the literature of animal husbandry reveals that this drug, when administered in doses far greater than those required for bronchodilation, does indeed increase the deposition rate of lean mass and retard adipose gain. There are no human studies available. Animal studies were conducted on laboratory and slaughter stock. No investigation into long-term cardiovascular side effects has been undertaken. The rate of extrapolation from animal studies to unsupervised human usage is alarming. If this category of drugs does preserve lean mass in humans, there are legitimate medical applications. Trials of efficacy and safety are needed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7476054

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  12 in total

Review 1.  Drugs and sport. Research findings and limitations.

Authors:  P M Clarkson; H S Thompson
Journal:  Sports Med       Date:  1997-12       Impact factor: 11.136

2.  Case of low dose clenbuterol toxicity.

Authors:  Michael Waight; William McGuinness
Journal:  BMJ Case Rep       Date:  2016-04-15

Review 3.  β₂ AR agonists in treatment of chronic heart failure: long path to translation.

Authors:  Mark I Talan; Ismayil Ahmet; Riu-Ping Xiao; Edward G Lakatta
Journal:  J Mol Cell Cardiol       Date:  2010-10-01       Impact factor: 5.000

4.  Effects of combined stretching and clenbuterol on disuse atrophy in rat soleus muscle.

Authors:  Toshiaki Yamazaki; Masami Yokogawa; Katsuhiko Tachino
Journal:  J Jpn Phys Ther Assoc       Date:  2009

5.  Effects of intermittent weight-bearing and clenbuterol on disuse atrophy of rat hindlimb muscles.

Authors:  Toshiaki Yamazaki
Journal:  J Jpn Phys Ther Assoc       Date:  2005

6.  Molecular impact of clenbuterol and isometric strength training on rat EDL muscles.

Authors:  Rémi Mounier; Hélian Cavalié; Gérard Lac; Eric Clottes
Journal:  Pflugers Arch       Date:  2006-11-09       Impact factor: 3.657

7.  β-Adrenergic stimulation does not activate p38 MAP kinase or induce PGC-1α in skeletal muscle.

Authors:  Sang Hyun Kim; Meiko Asaka; Kazuhiko Higashida; Yumiko Takahashi; John O Holloszy; Dong-Ho Han
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-02-26       Impact factor: 4.310

8.  Acute clenbuterol overdose resulting in supraventricular tachycardia and atrial fibrillation.

Authors:  G Patrick Daubert; Vincent H Mabasa; Vivian W Y Leung; Cynthia Aaron
Journal:  J Med Toxicol       Date:  2007-06

9.  Beta2 adrenergic agonist, clenbuterol, enhances working memory performance in aging animals.

Authors:  Brian P Ramos; Leslie A Colgan; Eric Nou; Amy F T Arnsten
Journal:  Neurobiol Aging       Date:  2007-03-23       Impact factor: 4.673

10.  Muscle wasting: an overview of recent developments in basic research.

Authors:  Sandra Palus; Stephan von Haehling; Jochen Springer
Journal:  J Cachexia Sarcopenia Muscle       Date:  2014-08-28       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.